The authors have evaluated a new procedure for the estimation of pancreatic and salivary isoamylase using a new selective inhibitor reagent (Enzamyl Isoamylase, Gödecke 1 ), Germany; composition covered by patent No. P 3404876.6). Provided the conditions of the assay presented here are correctly selected, a Standard curve is not necessary and the activities of both isoenzymes can be calculated by a simple* formula. In view of its rapidity and precision, this new procedure appears to be useful äs a screening test. It correlates closely with a reference electrophoretic method.
Introduction
he , inearity of ±e residuai ac tivity on The present study deals with a new procedure for reference fluids (saliva, duodenal fluid) after inhibimeasuring pancreatic isoamylase activity (Enzamyl tion under the suitable incubation conditions; Isoamylase, Gödecke'), ^ cov-^^ on ered by patent No. P 3404876.6). This procedure uses v ' * a wheat germ selective inhibitor which is already (iv) to compare the results obtained on sera by this knpwn (1-3), but obviates the need for a Standard new technique with those given by an electrophoretic eurve by selecting an inhibitor concentration capable method. of suppressing 50% of the panereatic isoenzyme activity and J00% of the salivary isoenzyme activity.
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Material and Methods
The ahn of this investigation was: Samples (i) to determine the ineubation conditions (time, tem, Fifteen duodenal fluid$ collected by duodenal mbing and forty pefature, reagent mixture) required for the Operation ser a were obtained from patients admitted to the wards. Saliva of the calculation principle proposed by the manufac-was collected from fifteen healthy volunteers, Special care was (6) .
Electrophoresis procedure
Cellulose acetate membranes were placed in 0.02 mol/l phosphate bufier (pH 7.40). After blotting, 3 μΐ of sample were applied at the mid-point. Samples with high amylase activity were diluted in the same buffer to give an activity afound 200 U/l. Electrophoresis was carried out at 4 °C in the same buffer at 300 V for 2 hours. 
Slaining reagent preparation
Blue starch tablets (Phadebas Amylase tablets) were ground to a fine powder in a mortar and mixed with 5 ml of 2% AgarNoble per tablet. The mixture was boiled for a further 30 min and then kept at 42 °C.
Staining procedure
At the end of electrophoresis, membranes were blotted^ stained by pouring the blue starch solution onto them and kept in an incubator at 37 °C for one hour. After removal of the blue starch gel, the cleaned and dried membranes were scanned in a Beckman integrator (R112-115) using a 0.4 mm · 5 mm slit beam (620 nm).
α-Amylase isoenzyme measurement by the selective inhibition method
Inhibitor solution (Enzamyl Isoamylase, G decke 1 ), Germany; composition covered by patent No. P 3404876.6) and sample were mixed in equal volumes. After incubation, the residual aamylase activity was measured and the results calculated s follows:
l. pancreatic isoamylase activity (U/l) = residual activity · 4, where 4 represents the sample/inhibitor predilution (· 2) and the 50% inhibition of pancreatic isoenzyme; 2.0 2. salivary isoamylase activity (U/l) creatic activity.
total activity -pan-
Results
Validation of experimental conditions and calculation procedure achieved at a preincubation time of 60 min onwards: more than 90% for saliva, aro nd 45-50% for duodenal fluid and 60% for serum.
The temperature of preincubation does not influence the res lt; no difference was f und between experiments performed at 25 °C and 37 °C; however results obtained at 25 °C were more scattered owing to the low residual activities (approaching the detection limit) recorded at that temperature. Figure 2 presents the results of a continuous assay where 50 μΐ of Inhibitor, 50 μΐ of serum and l ml reagent were mixed at once aq^ the kinetics recorded on a spectrophotometer Beckman (model 25). In 3 sera, total activity was estimated from the extrapolation of the initial rate and residual activity after Inhibition from the second slope. These res lts were compared with those obtained with the same sera by a two-step procedure. This comparison reveals that neither total activity nor maximal Inhibition could be correctly estimated by the one-step procedure and that their reliable determinations require preliminary measurement of total activity and a one hour preincubation with the inhibitor. Figure 3 shows the residual activities recorded when a same voluine (50 μΐ) of sample (duodenal fluid or saliva) was preincubated with increasing volumes of the inhibiting solution. This graph reveals that a 50% of pancreatic amylase activity was only obtained for a l/l (v : v) sample-inhibitor ratio.
Another set of 3 experiments was devised to validate the calculation procedure. One aliquot of duodenal juice and a second one preincubated for l hour with the Inhibition solution (1:1) were submitted to electrophoresis; after staining, the electrophoretic spots were scanned in a direction perpendicular to the line of migration (fig. 4) . The res lts show that the ratio between the areas of initial and residual activities ranged from 77-23% to 83-17% and thus came close to the 80-20% ratio expected from the theoretical calculation. 
Linearity of reaction
Total and residual α-amylase activities measured in saliva and duodenal fluid under the preincubation conditions selected are plotted in figure 5 against the corresponding dilutions. The assay is linear up to 350 U/l for total activity and at least up to 200 U/l for residual activity after Inhibition. It must be noticed that in the case of salivary amylase, Inhibition was never complete: above 1.00 U/l total activity, a 5% residual activity was always observed. Between assays precision Twenty sera were repeatedly estimated in 6 assays: the coefficients of Variation never exceeded 2% for total amylase activities and increased up to 3.6% for residual activities above 10 U/l and to 12.5% for still lower values approaching detection limit. It must however be noted that even in these last cases, the Standard deviation of between assays precision remained äs low äs 0.5 U/l.
Comparison to a reference method
In figure 6 the values obtained from 22 sera by the selective Inhibition technique (ordinates) are plotted against the corresponding values given by the electrophoretic method (abscissa). The formula of the regression line was y = 1.02 + 2 and its slope was not significantly different from the identity line = 1.00 (t = 0.6338, p > 0.50); moreover the Standard deviation from regression was equal to 10 U/l (/. e. a CV of 12% for mean value). These features emphasize the similarity of results provided by both methods. 
Discussion
The present evaluation based upon the use of reference fluids reveals that the type of calculation forwarded by the manufacturer to estimate the Contents in pancreatic and salivary amylase activities of biological fluids is valid providing folldwing conditions are fulfilled:
-the use of a two-step procedure with determination of total activity in one aliquot, and of residual activity after selective Inhibition in a different aliquot. -a l/l (v : v) ratio between sample and inhibiting mixture; -a one hour incubation of sample and inhibiting mixture before measuring residual activity; -a residual activity after Inhibition greater than 5% of total activity.
The last condition is based on the fact that Inhibition of salivary amylase never exceeded 95% of total activity. Application of the calculation formula for total activity concentfations greater than 300 U/l would thus provide a value above 30 U/l for the pancreatic component even in the case of a hyperamylasaemia of pure salivary origin.
Applied to sera täken at random, this technique has provided results superimposable on those obtained with an electrophoretic reference method.
The repeatablility of the technique is quite satisfactory except for very low residual values that can only be observed with fluids displaying a poor content of pancreatic amylase and a high content of the salivary isoenzyme. However, it must be noted that this assay is primarily designed to estimate with precision the pancreatic component in hyperamylasaemia of doubtful aetiology, a Situation that is often encquntered when amylasaemia rises two-or three-fold above the upper normal limit (7, 8) . In this Situation, the new assay may be suggested äs a suitable screening test, in view öf its linearity, its repeatablility and its simplicity linked the fact that ä Standard curve is not needed. Nevertheless, a careful evaluation of this assay in pancreatitis attacks is still to be made, in order to assign its place among the other diagnostic tests. Indeed it must be remembefed that simultaneous determination of amylase and pancreatic lipase in plasma by rapid and accurate methods has already achieved a very high level of confideüce for the detection of acute or relapsing pancreatic disorders (7* 8).
